• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性、癌前和良性宫颈病变中的端粒酶活性与人乳头瘤病毒

Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions.

作者信息

Mutirangura A, Sriuranpong V, Termrunggraunglert W, Tresukosol D, Lertsaguansinchai P, Voravud N, Niruthisard S

机构信息

Department of Anatomy, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

出版信息

Br J Cancer. 1998 Oct;78(7):933-9. doi: 10.1038/bjc.1998.604.

DOI:10.1038/bjc.1998.604
PMID:9764586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2063133/
Abstract

The purpose of this study was to define a correlation between telomerase activity and human papillomavirus (HPV) in normal control tissue and in benign, premalignant and malignant cervical lesions. Telomerase activity was detectable in 33 out of 34 cases of squamous-cell carcinoma, five out of six cases of microinvasive carcinoma, 8 out of 20 cases and two out of six cases of high- and low-grade squamous intraepithelial lesions (SILs) respectively. The higher frequency of positive telomerase in invasive carcinoma compared with SILs was observed in both HPV-associated and non-associated groups. Whereas 92.6% of HPV-positive and 100% of HPV-negative invasive lesions expressed telomerase, only 50% of HPV-positive and 25% of HPV-negative SILs did. Interestingly, telomerase activity was also detectable in 13 out of 28 cases of benign lesions regardless of the presence of HPV. In conclusion, there may be two roles of telomerase in the cervix. The first one would present in benign lesions; the second is associated with cancer development and activated during the late stage of multistep carcinogenesis in both HPV-positive and -negative groups.

摘要

本研究的目的是确定端粒酶活性与正常对照组织以及良性、癌前和恶性宫颈病变中的人乳头瘤病毒(HPV)之间的相关性。在34例鳞状细胞癌中的33例、6例微浸润癌中的5例、20例高级别和低级别鳞状上皮内病变(SIL)中的8例以及6例中的2例中分别检测到端粒酶活性。在HPV相关和非相关组中,均观察到浸润癌中端粒酶阳性频率高于SIL。92.6%的HPV阳性和100%的HPV阴性浸润性病变表达端粒酶,而HPV阳性SIL中只有50%,HPV阴性SIL中只有25%表达端粒酶。有趣的是,无论HPV是否存在,28例良性病变中的13例也可检测到端粒酶活性。总之,端粒酶在宫颈中可能有两种作用。第一种作用存在于良性病变中;第二种作用与癌症发展相关,并在HPV阳性和阴性组的多步骤致癌作用晚期被激活。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbcd/2063133/5b50d2ec46fc/brjcancer00011-0102-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbcd/2063133/8879090d6553/brjcancer00011-0098-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbcd/2063133/6ca9ea64cdc4/brjcancer00011-0100-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbcd/2063133/e677b8ac484c/brjcancer00011-0102-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbcd/2063133/5b50d2ec46fc/brjcancer00011-0102-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbcd/2063133/8879090d6553/brjcancer00011-0098-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbcd/2063133/6ca9ea64cdc4/brjcancer00011-0100-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbcd/2063133/e677b8ac484c/brjcancer00011-0102-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbcd/2063133/5b50d2ec46fc/brjcancer00011-0102-b.jpg

相似文献

1
Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions.恶性、癌前和良性宫颈病变中的端粒酶活性与人乳头瘤病毒
Br J Cancer. 1998 Oct;78(7):933-9. doi: 10.1038/bjc.1998.604.
2
Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix.子宫颈鳞状上皮内病变及鳞状细胞癌中端粒酶激活与HPV 16/18癌基因表达的关系。
Int J Gynecol Pathol. 2001 Apr;20(2):177-85. doi: 10.1097/00004347-200104000-00011.
3
Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.一组马来西亚患者浸润性子宫颈癌中的端粒酶激活与人乳头瘤病毒感染
J Clin Pathol. 2002 Jan;55(1):22-6. doi: 10.1136/jcp.55.1.22.
4
[Contribution of high risk human papillomavirus testing to the management of premalignant and malignant lesions of the uterine cervix].[高危型人乳头瘤病毒检测对子宫颈癌前病变和恶性病变管理的贡献]
Med Clin (Barc). 2003 Oct 11;121(12):441-5. doi: 10.1016/s0025-7753(03)73985-2.
5
Relationship between the expression of telomerase and human papillomavirus infection in invasive uterine cervical carcinoma.浸润性子宫颈癌中端粒酶表达与人乳头瘤病毒感染之间的关系。
J Huazhong Univ Sci Technolog Med Sci. 2007 Aug;27(4):451-3. doi: 10.1007/s11596-007-0426-1.
6
Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears.人子宫颈癌及宫颈涂片中的端粒酶活性与人乳头瘤病毒(HPV)感染
Eur J Cancer. 1998 Dec;34(13):2082-6. doi: 10.1016/s0959-8049(98)00242-1.
7
Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix.
Am J Clin Pathol. 1998 Feb;109(2):153-62. doi: 10.1093/ajcp/109.2.153.
8
High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix.高危型人乳头瘤病毒感染及子宫颈病变中E6蛋白的表达
Pathobiology. 1998;66(5):240-6. doi: 10.1159/000028029.
9
Telomerase--a potential molecular marker of lung and cervical cancer.端粒酶——肺癌和宫颈癌的一种潜在分子标志物。
Clin Chem Lab Med. 2002 Oct;40(10):994-1001. doi: 10.1515/CCLM.2002.173.
10
Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.宫颈癌及癌前病变中端粒酶活性的半定量分析
Oncol Rep. 1999 Mar-Apr;6(2):325-8.

引用本文的文献

1
Lab-on-chip assay of tumour markers and human papilloma virus for cervical cancer detection at the point-of-care.即时检测点的用于宫颈癌检测的肿瘤标志物和人乳头瘤病毒的芯片实验室检测。
Sci Rep. 2022 May 24;12(1):8750. doi: 10.1038/s41598-022-12557-y.
2
Loop-Mediated Isothermal Amplification Assay for Detecting Tumor Markers and Human Papillomavirus: Accuracy and Supplemental Diagnostic Value to Endovaginal MRI in Cervical Cancer.用于检测肿瘤标志物和人乳头瘤病毒的环介导等温扩增检测法:对宫颈癌阴道内磁共振成像的准确性及补充诊断价值
Front Oncol. 2021 Nov 1;11:747614. doi: 10.3389/fonc.2021.747614. eCollection 2021.
3
Telomerase Induction in HPV Infection and Oncogenesis.

本文引用的文献

1
Telomerase activation in in vitro and in vivo cervical carcinogenesis.
Gynecol Oncol. 1997 Aug;66(2):222-6. doi: 10.1006/gyno.1997.4757.
2
Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells.
Blood. 1997 Jul 1;90(1):182-93.
3
Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP).通过端粒重复序列扩增法(TRAP)对端粒酶活性进行定量和表征的进展。
Nucleic Acids Res. 1997 Jul 1;25(13):2595-7. doi: 10.1093/nar/25.13.2595.
4
人乳头瘤病毒感染与肿瘤发生中的端粒酶诱导作用
Viruses. 2017 Jul 10;9(7):180. doi: 10.3390/v9070180.
4
The status of telomerase enzyme activity in benign and malignant gynaecologic pathologies.端粒酶酶活性在良性和恶性妇科学病理中的状态。
Balkan Med J. 2013 Sep;30(3):287-92. doi: 10.5152/balkanmedj.2013.7328. Epub 2013 Sep 1.
5
Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer.人乳头瘤病毒相关宫颈癌中细胞周期蛋白A1启动子的高甲基化
BMC Cancer. 2006 Mar 8;6:55. doi: 10.1186/1471-2407-6-55.
6
Potential of telomerase expression and activity in cervical specimens as a diagnostic tool.宫颈标本中端粒酶表达及活性作为诊断工具的潜力。
J Clin Pathol. 2005 Sep;58(9):911-4. doi: 10.1136/jcp.2004.024158.
7
Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology.液基宫颈细胞学中的染色体原位杂交、Ki-67和端粒酶免疫细胞化学
J Clin Pathol. 2004 Jul;57(7):721-7. doi: 10.1136/jcp.2003.013730.
8
Progressive transformation of immortalized esophageal epithelial cells.永生化食管上皮细胞的渐进性转化。
World J Gastroenterol. 2002 Dec;8(6):976-81. doi: 10.3748/wjg.v8.i6.976.
9
Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity.用乳头瘤病毒E6/E7癌基因转导的宫颈上皮细胞维持癌蛋白表达的稳定水平,但hTERT基因表达和端粒酶活性呈现出逐渐的、显著的增加。
Am J Pathol. 2002 Apr;160(4):1251-7. doi: 10.1016/S0002-9440(10)62552-7.
10
Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell.食管上皮细胞永生化初期的端粒与端粒酶
World J Gastroenterol. 2002 Apr;8(2):357-62. doi: 10.3748/wjg.v8.i2.357.
Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions.
J Clin Oncol. 1997 May;15(5):1932-7. doi: 10.1200/JCO.1997.15.5.1932.
5
Application of telomerase assay for the screening of cervical lesions.
Cancer Res. 1997 May 15;57(10):1863-7.
6
Telomerase in the early detection of cancer.端粒酶在癌症早期检测中的应用
J Clin Pathol. 1997 Feb;50(2):106-9. doi: 10.1136/jcp.50.2.106.
7
The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length.人乳头瘤病毒16型E6和E7癌蛋白使细胞端粒酶活性与端粒长度维持相分离。
J Biol Chem. 1997 May 16;272(20):13332-7. doi: 10.1074/jbc.272.20.13332.
8
Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q.16型和18型人乳头瘤病毒转染的人包皮角质形成细胞向永生化的转变:端粒酶激活及3p、10p、11q和/或18q处的等位基因缺失
Oncogene. 1996 Sep 19;13(6):1249-57.
9
Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma.口腔白斑和头颈部鳞状细胞癌中的端粒酶活性。
Cancer Res. 1996 Aug 1;56(15):3530-3.
10
Telomerase activity in normal human epithelial cells.正常人上皮细胞中的端粒酶活性。
Oncogene. 1996 Jul 18;13(2):433-9.